Medinex (SGX:OTX) 10-Year RORE % : 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SGX:OTX Medinex Ltd SGX:OTX
67 GF Score
Price S$0.21
GF Value S$0.20
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Medinex 10-Year RORE %?

Medinex SGX:OTX -4.55% 67 10-Year RORE % is 0.00 as of Mar. 2026. GuruFocus rates SGX:OTX with a GF Score™ of 67/100 and a GF Value™ of S$0.20 (Fairly Valued). The stock has 2 warning signs investors should review. Among 326 Healthcare Providers & Services companies, Medinex ranks worse than 306748.16% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Medinex does not have enough data to calculate 10-Year RORE %.


Medinex  (SGX:OTX) 10-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Medinex 10-Year RORE % Related Terms


Medinex 10-Year RORE % Historical Data

* Premium members only.

The historical data trend for Medinex's 10-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medinex 10-Year RORE % Chart

Medinex Annual Data
Trend Dec16 Dec17 Dec18 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
10-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medinex Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
10-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

SGX:OTX vs HCA, THC, EHC: 10-Year RORE % Comparison

For the Medical Care Facilities subindustry, Medinex's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medinex 10-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medinex's 10-Year RORE % distribution charts can be found below:

* The bar in red indicates where Medinex's 10-Year RORE % falls into.


SGX:OTX
67GF Score
Medinex Ltd SGX:OTX
10-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medinex 10-Year RORE % Calculation

Medinex's 10-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

10-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 10-year -Cumulative Dividends per Share for 10-year )
=( - )/( - )
=/
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 10-year before.

Frequently Asked Questions Learn more about 10-Year RORE % →
What does a 10-Year RORE % of 0.00 mean?
Medinex (SGX:OTX) has a 10-Year RORE % of 0.00 as of Mar. 2026. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on Medinex and its competitors. According to the industry distribution chart, Medinex ranks #999999 out of 326 companies in the Healthcare Providers & Services industry.
Is Medinex's 10-Year RORE % too high?
Medinex's current 10-Year RORE % is 0.00. Based on the distribution chart, Medinex ranks #999999 out of 326 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Medinex has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medinex's 10-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medinex ranks #999999 out of 326 companies for 10-Year RORE %. This places Medinex in the lower half of its industry. The industry median 10-Year RORE % is 7.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year RORE % for a Healthcare Providers & Services company?
The median 10-Year RORE % among Healthcare Providers & Services companies is 7.15, based on 326 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year RORE % mean?
A high 10-Year RORE % can signal that a stock is expensive relative to its fundamentals. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on Medinex and its competitors. For the Healthcare Providers & Services industry, the median 10-Year RORE % is 7.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medinex's current 10-Year RORE % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinex stock overvalued right now?
Based on GuruFocus' analysis, Medinex (SGX:OTX) is currently considered Fairly Valued. The stock's GF Value™ is S$0.20, compared to a current price of S$0.21 — trading 5% above its estimated fair value. The current 10-Year RORE % is 0.00. Medinex's overall GF Score™ is 67/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year RORE % calculated?
10-Year RORE % is calculated from a company's financial statements. For Medinex (SGX:OTX), the current 10-Year RORE % is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medinex (SGX:OTX) Overvalued in 2026?

Based on GuruFocus' analysis, Medinex stock appears to be overvalued. The current stock price of S$0.21 is trading 5% above its estimated GF Value™ of S$0.20. GuruFocus considers Medinex to be Fairly Valued.

Key valuation signals for SGX:OTX:

  • 10-Year RORE %: 0.00
  • GF Value™: S$0.20 vs. price of S$0.21 (5% above fair value)
  • GF Score™: 67/100 with 2 warning signs

No single metric tells the full story. See the SGX:OTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medinex Business Description

Address 111 North Bridge Road, No. 23-04, Peninsula Plaza, Singapore, SGP, 179098
Medinex Ltd is an investment holding company. The company has four business segments: Medical Support Services, Business Support Services, Pharmaceutical Services, and Medical Services. The company generates maximum revenue from the Business Support Services segment. The Business support services business segment provides professional services to customer base who are outside from healthcare industry.
67GF Score

Get the complete analysis for SGX:OTX

10-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

S$0.21
Price
S$0.20
GF Value